CD38 and Miyoshi myopathy: By labelling a CD38-specific nanobody (Nb1053) with gallium-68 (Wang et al., 2021) or fluorine-18 (Wei et al., 2021), two preclinical studies indicated that Nb1053-based molecular imaging radiotracers may be useful for MM diagnosis and follow-up (listed in Table 3).